
JPMORGAN AMERICAN INVESTMENT TRUST PLC
(the 'Company')
Legal Entity Identifier: 549300QNAI4XRPEB4G65
Investor Webinar: 9th October 2025 3:00 p.m. BST
The Company is pleased to announce that Jack Caffrey, portfolio manager, will be providing an update on the Company, on Thursday, 9th October 2025 3:00 p.m. BST. Jack will provide an update on the US market outlook before delving into portfolio enhancements, positioning and recent performance of the trust.
There will be a Questions and Answers session at the end of the presentation. Attendees will have the opportunity to submit questions online over the course of the webinar.
As a reminder JAM is constructed of approximately 20 'Growth' stocks and 20 'Value' stocks that represent the managers' best ideas, designed to outperform the S&P 500 across market cycles. The trust is priced at 35bps and has outperformed the benchmark, net of fees, over 3, 5 and 10 years.
The webinar is open to all existing and prospective shareholders. Registration is free and can be accessed here. A replay will also be made available to those who register.
Other opportunities to hear from the portfolio manager:
Jack Caffrey will be presenting at the Association of Investment Companies (AIC) Investment Company Showcase on Friday, 10th October 2025 at 10:15 a.m. Jack will explain why he thinks the US is still an essential allocation for investors' portfolios.
Following his presentation, Jack will join a panel session at 11:25. The panel will reflect on the Trump presidency to date and whether his policies are helping or hindering the prospects for US and global equities.
Registration for in-person or digital access to the Showcase can be accessed here.
For further information, please contact:
Investment Trust Sales
E-mail: Investment_trust_sales@jpmorgan.com
Tel: 0203 493 5904
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.